Literature DB >> 32687675

lncRNA ZEB2-AS1: A promising biomarker in human cancers.

Zarei Mahboobeh1, Mousavi Pegah1, Sadri Fatemeh1, Karimi Elham1, Azari Hanieh1, Rafat Milad1, Shekari Mohammad1.   

Abstract

Long non-coding RNAs (lncRNAs) are one of the ncRNAs that transcript with length more than 200 nt that are not translated into protein. Studies have shown that lncRNAs have regulatory function in human disease especially cancers. lncRNA dysfunction causes altered cellular behavior including proliferation, invasion, and migration, and also it can inhibit apoptosis. Long non-coding zinc finger E-box binding homeobox 2 antisense RNA1 (lnZEB2-AS1) is one of the lncRNAs that plays the oncogenic role in different cancers. Dysregulation of lncZEB2-AS1 can lead to tumorigenesis and cancer progression. lncZEB2-AS1 may be introduced as a diagnostic marker or therapeutic target for human cancers. In this review, we describe briefly the mechanism of ZEB2-AS1 in cells and its function in cancer progression.
© 2020 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  TGFβ; biomarker; cancer; lncRNA ZEB2-AS1; non-coding RNA

Year:  2020        PMID: 32687675     DOI: 10.1002/iub.2338

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  5 in total

1.  Machine Learning-Devised Immune-Related lncRNA Signature Panel Predicts the Prognosis and Immune Landscape in Breast Cancer Novel IRLP Signature in BRCA.

Authors:  Jun-Yu Zhu; An-Qi Lyu; Zhang-Ting Wang; Wai-Yee Chan; Tao Qin; Kai-Kei Miu; He-Rui Yao
Journal:  J Immunol Res       Date:  2022-08-18       Impact factor: 4.493

Review 2.  Natural antisense transcripts as drug targets.

Authors:  Olga Khorkova; Jack Stahl; Aswathy Joji; Claude-Henry Volmar; Zane Zeier; Claes Wahlestedt
Journal:  Front Mol Biosci       Date:  2022-09-27

Review 3.  Molecular Mechanisms of lncRNAs in the Dependent Regulation of Cancer and Their Potential Therapeutic Use.

Authors:  Carlos García-Padilla; Ángel Dueñas; Virginio García-López; Amelia Aránega; Diego Franco; Virginio Garcia-Martínez; Carmen López-Sánchez
Journal:  Int J Mol Sci       Date:  2022-01-11       Impact factor: 5.923

4.  Long Non-Coding RNAs Expression in Breast Cancer: CBR3-AS1 LncRNA as a Sensitive Biomarker.

Authors:  Safora Torkashvand; Ali Basi; Hossein Ajdarkosh; Nasser Rakhshani; Nahid Nafisi; Seyed Javad Mowla; Ayda Moghadas; Mahshid Mohammadipour; Mohammad Hadi Karbalaie Niya
Journal:  Asian Pac J Cancer Prev       Date:  2021-09-01

Review 5.  Exosomal noncoding RNAs: key players in glioblastoma drug resistance.

Authors:  Ahmad Movahedpour; Seyyed Hossein Khatami; Marjan Khorsand; Mahsa Salehi; Amir Savardashtaki; Seyedeh Habibeh Mirmajidi; Babak Negahdari; Nezhat Khanjani; Parisa Naeli; Omid Vakili; Mortaza Taheri-Anganeh
Journal:  Mol Cell Biochem       Date:  2021-07-17       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.